453 Results

People

  1. Kelsen
    Kelsen
  2. Motzer
    Motzer
  3. Kris
    Kris
  4. Saltz
    Saltz
  5. Abrey
    Abrey
  6. O'Reilly
    O'Reilly
  7. Schwartz
    Schwartz
  8. Hudis
    Hudis
  9. Aghajanian
    Aghajanian
  10. De Angelis
    De Angelis

Groups

  1. Department of Medicine (312)
  2. Solid Tumor Oncology Division (250)
  3. Survivorship Research (79)
  4. Gastrointestinal Oncology Service (76)
  5. Hematologic Malignancies, Division of (76)
  6. Radiology, Department of (64)
  7. Center for Hematologic Malignancies (63)
  8. Epidemiology and Biostatistics (61)
  9. Biostatistics Service (60)
  10. Genitourinary Oncology Service (59)
  1. "leukopenia"
Formats
  1. Journal Article (435)
  2. Review (9)
  3. Conference Paper (4)
  4. Editorial (2)
  5. Research Letter (2)
  6. Miscellaneous (1)
Groups
  1. Department of Medicine (312)
  2. Solid Tumor Oncology Division (250)
  3. Survivorship Research (79)
  4. Gastrointestinal Oncology Service (76)
  5. Hematologic Malignancies, Division of (76)
  6. Radiology, Department of (64)

More Groups

People
  1. David Kelsen (33)
  2. Robert Motzer (29)
  3. Mark Kris (25)
  4. Leonard Saltz (21)
  5. Eileen O'Reilly (18)
  6. Lauren Abrey (18)

More People

Years
  1. 2025 (10)
  2. 2024 (26)
  3. 2023 (9)
  4. 2022 (8)
  5. 2021 (6)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (42)
  2. Cancer (33)
  3. Clinical Cancer Research (33)
  4. Annals of Oncology (15)
  5. Gynecologic Oncology (14)
  6. Investigational New Drugs (14)

More Publications

Publishers
  1. Elsevier Inc. (68)
  2. Springer (52)
  3. American Society of Clinical Oncology (43)
  4. Wiley Blackwell (39)
  5. American Association for Cancer Research (36)
  6. Oxford University Press (33)

More Publishers

Results (453)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ixabepilone plus capecitabine for breast cancer patients with an early metastatic relapse after adjuvant chemotherapy: Two clinical trials
    Journal Article

    Fornier, M.
    Clinical Breast Cancer (2010)

    Fulltext@MSK | Save
  • Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors
    Journal Article

    Feldman, D. R.; Turkula, S.; Ginsberg, M. S.; Ishill, N.; Patil, S.; Carousso, M.; Bosl, G. J.; Motzer, R. J.
    Investigational New Drugs (2010)

    Fulltext@MSK | Save
  • Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: A gynecologic oncology group study
    Journal Article

    Farley, J. H.; Tian, C.; Rose, G. S.; Brown, C. L.; Birrer, M.; Risinger, J. I.; Thigpen, J. T.; Fleming, G. F.; Gallion, H. H.; Maxwell, G. L.
    Cancer (2010)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol
    Journal Article

    Dickson, M. A.; Shah, M. A.; Rathkopf, D.; Tse, A.; Carvajal, R. D.; Wu, N.; Lefkowitz, R. A.; Gonen, M.; Cane, L. M.; Dials, H. J.; more...
    Cancer Chemotherapy and Pharmacology (2010)

    Fulltext@MSK | Save
  • Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea
    Journal Article

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Sugarman, S.; Morris, P.; Abbruzzi, A.; Chen, C.; Steingart, R.; Patil, S.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer
    Journal Article

    Conlin, A.; Seidman, A.; Bach, A.; Lake, D.; Dickler, M.; D'Andrea, G.; Traina, T.; Danso, M.; Brufsky, A.; Saleh, M.; more...
    Clinical Breast Cancer (2010)

    Fulltext@MSK | Save
  • Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: Evidence of symptom palliation from chemotherapy
    Journal Article

    Cianfrocca, M.; Lee, S.; Von Roenn, J.; Tulpule, A.; Dezube, B. J.; Aboulafia, D. M.; Ambinder, R. F.; Lee, J. Y.; Krown, S. E.; Sparano, J. A.
    Cancer (2010)

    Fulltext@MSK | Save
  • Evolving treatment of advanced colorectal cancer
    Journal Article

    Cercek, A.; Saltz, L.
    Current Oncology Reports (2010)

    Fulltext@MSK | Save
  • Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor
    Journal Article

    Butrynski, J. E.; D'adamo, D. R.; Hornick, J. L.; Cin, P. D.; Antonescu, C. R.; Jhanwar, S. C.; Ladanyi, M.; Capelletti, M.; Rodig, S. J.; Ramaiya, N.; more...
    New England Journal of Medicine (2010)

    Fulltext@MSK | Save
  • The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: Well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum
    Journal Article

    Boudreaux, J. P.; Klimstra, D. S.; Hassan, M. M.; Woltering, E. A.; Jensen, R. T.; Goldsmith, S. J.; Nutting, C.; Bushnell, D. L.; Caplin, M. E.; Yao, J. C.
    Pancreas (2010)

    Fulltext@MSK | Save